Philip Pancari

625 total citations
6 papers, 76 citations indexed

About

Philip Pancari is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Philip Pancari has authored 6 papers receiving a total of 76 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Hematology and 2 papers in Oncology. Recurrent topics in Philip Pancari's work include Acute Myeloid Leukemia Research (3 papers), Cancer therapeutics and mechanisms (1 paper) and Mast cells and histamine (1 paper). Philip Pancari is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), Cancer therapeutics and mechanisms (1 paper) and Mast cells and histamine (1 paper). Philip Pancari collaborates with scholars based in United States. Philip Pancari's co-authors include Russell L. Widom, Robert Lafyatis, Giuseppina Farina, Raphaël Lemaire, J Bayle, Ranee Mehra, Roma Patel, Nasheed Hossain, Xuelin Huang and Henry C. Fung and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of the Rheumatic Diseases.

In The Last Decade

Philip Pancari

4 papers receiving 75 citations

Peers

Philip Pancari

PFM

MB

IMMUN

DERMA

PRM

Blandine Fabre France

Estelle Jean France

André Coelho Portugal

Margareth Macro France

Kiyohiro Tsutsui Japan

N. Susan United States

Masahiro Matsunaka Japan

Giulia Francesca Manfredi Italy

Yusuke Sugimori Japan

Rachel Bright-Thomas United Kingdom

Blandine Fabre France

Philip Pancari

45 ×1.4

PFM

11 ×0.5

MB

18 ×1.1

IMMUN

19 ×1.2

DERMA

6 ×0.4

PRM

Citations per year, relative to Philip Pancari Philip Pancari (= 1×) peers Blandine Fabre

Countries citing papers authored by Philip Pancari

Since Specialization

Citations

This map shows the geographic impact of Philip Pancari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Pancari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Pancari more than expected).

Fields of papers citing papers by Philip Pancari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Pancari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Pancari. The network helps show where Philip Pancari may publish in the future.

Co-authorship network of co-authors of Philip Pancari

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Pancari. A scholar is included among the top collaborators of Philip Pancari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Pancari. Philip Pancari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Parkin, Brian, et al.. (2024). Venetoclax combined with hypomethylating agents for favorable risk acute myeloid leukemia: A single center experience.. Journal of Clinical Oncology. 42(16_suppl). e18514–e18514.

2.

Parkin, Brian, et al.. (2024). Omission of Venetoclax Ramp-up Dosing during Induction Therapy for Acute Myeloid Leukemia in Combination with DNA Hypomethylating Agents Is Safe and Well-Tolerated. Blood. 144(Supplement 1). 4241–4241.

3.

Wang, Trent, Carlyn Tan, Nasheed Hossain, et al.. (2017). CMV and BK Virus Reactivation in Post Transplant Cyclophosphamide (PTCY) after Allogeneic MUD, MRD and Haploidentical Transplant. Biology of Blood and Marrow Transplantation. 23(3). S305–S306. 2 indexed citations

4.

Kropf, Patricia, Philip Pancari, Henry C. Fung, et al.. (2016). Improved Survival for MDS/CMML Patients Treated with the Combination of Decitabine (DAC) and Arsenic Trioxide (ATO) in a Phase II Adaptive Three Arm Randomization Study: DAC Alone Vs. DAC +/- Carboplatin or ATO. Blood. 128(22). 3170–3170. 1 indexed citations

5.

Pancari, Philip & Ranee Mehra. (2015). Systemic Therapy for Squamous Cell Carcinoma of the Head and Neck. Surgical Oncology Clinics of North America. 24(3). 437–454. 8 indexed citations

6.

Farina, Giuseppina, Raphaël Lemaire, Philip Pancari, et al.. (2008). Cartilage oligomeric matrix protein expression in systemic sclerosis reveals heterogeneity of dermal fibroblast responses to transforming growth factor β. Annals of the Rheumatic Diseases. 68(3). 435–441. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact